XinKailian Biotechnology (Hainan) Co., Ltd.Has Launched A Gmp-Certified Reduced Coenzyme Q10 With Patented Safety. The Product Will Debut At Vitafoods Asia 2024.

As a prominent player in the nutritional supplement industry, Xinkailian Biotechnology (Hainan) Co., Ltd. proudly announced the launch of its GMP-certified Ubiquinol (reduced coenzyme Q10) product on September 15, 2024. The product has completely independent intellectual property rights and complete system certification, and its quality meets the USP43 standard. Based on extensive FTO research and analysis, the product does not have the patent risk issues that are generally concerned in the industry, allowing customers to buy and use it with confidence. It will make its first public appearance at Vitafoods Asia 2024.

Comprehensive "FTO" analysis eliminates patent risks

As market concerns about potential patent infringement lawsuits grow, Xinkailian conducted a comprehensive "FTO" analysis. Of the 598 patents screened, 62 were relevant. Of these, 16 were classified as low risk and 46 were considered no risk. No high-risk or medium-risk patents were found. This rigorous evaluation was completed by Beijing Jijia Law Firm and verified by US law firm Kilpatrick Townsend & Stockton LLP, ensuring that downstream users can transition to Xinkailian's reduced coenzyme Q10 with peace of mind without the risk of legal consequences.

Committed to high-end product quality through advanced production technology

Sino-Kailian uses advanced technology to produce reduced coenzyme Q10, aiming to ensure the purity and effectiveness of the product. Its raw material, coenzyme Q10, is derived from a natural fermentation process, ensuring the excellent quality of downstream products. In addition, mild reaction conditions and ultra-low temperature treatment are used to maintain the biological activity of reduced coenzyme Q10, enhancing the absorbability and stability of the product. This commitment to innovation reflects the dedication of Sino-Kailian to quality in the competitive nutritional supplement market.

GMP certified, ready for the global market

Sino-Kailian's advanced production facilities, abundant production capacity, and standardized management (GMP) not only ensure the excellent and stable quality of its products, but also meet the global market demand. The company provides competitive products, enabling enterprises to maintain the highest quality standards while increasing profit margins.

Let's meet at Vitafoods Asia 2024

Xinkailian Biotech (Hainan) Co., Ltd. will showcase its latest GMP-certified reduced coenzyme Q10 at Vitafoods Asia 2024, held at the Queen Sirikit National Convention Center in Bangkok, Thailand, from September 18 to 20. Welcome new and old friends to visit our booth at Yili Chuan Ning Biotech Co., Ltd., booth number S10. As a partner of Kelun Group, one of the three largest pharmaceutical manufacturers in China, Xinkailian is pleased to launch this innovative product and enter the nutraceutical market.

About XinKailian Biotechnology (Hainan) Co., Ltd.

XinKailian Biotechnology (Hainan) Co., Ltd. specializes in producing high-quality reduced coenzyme Q10 and its products, which are essential ingredients for cardiovascular health, neuroprotection and anti-aging applications. The company's investment in GMP certification and USP43 compliance ensures that its products meet the highest industry standards for safety, efficacy and quality.

For more information, please visit XinKailian's booth at Vitafoods Asia 2024, booth number S10, or contact us directly.